Dr. Apple’s lab endures in Heidelberg
By Jennifer A. WebbHeidelberg, Germany—The late David J. Apple, MD, spent his life investigating the successes and failures of IOLs right up until his death in 2011. Today, his groundbreaking work...
View ArticleDry eye common, but complicated
Take home Despite the fact that dry eye is a very common complaint and a very common symptom, ophthalmologists must be familiar with its various signs, be able to assess severity, and treat it...
View ArticleAmniotic membrane platform provides active therapy
TAKE HOME: A cryopreserved amniotic membrane in a self-retaining device allows early in-office intervention to reduce inflammation and promote regenerative healing in eyes with a variety of ocular...
View ArticleManaging the acute red eye
Take-home To improve clinical accuracy and manage acute conjunctivitis better, one ophthalmologist’s practice has implemented a red eye protocol. This protocol is designed to improve diagnostic...
View ArticleARMOR Study: 4-year data on antibiotic resistance of ocular pathogens
TAKE HOME: Analyses of antimicrobial susceptibility testing of ocular isolates collected during 2012 in the Antibiotic Resistance Monitoring in Ocular MicroRganisms (ARMOR) surveillance study...
View ArticleHow to have healthy awareness and educate yourself regarding ACOs, expert...
Take Home An examination on accountable care organizations and how they may impact ophthalmology. By Stephanie SkernivitzIncline Village, NV—An author once said that the first step toward change is...
View Article
